NCT00262886View on ClinicalTrials.gov

Donor Peripheral Stem Cell or Bone Marrow Transplant in Treating Patients With Relapsed or Refractory Metastatic Kidney Cancer

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 31, 2001

Primary Completion Date

July 31, 2007

Conditions

Kidney Cancer

Interventions

BIOLOGICAL

anti-thymocyte globulin

BIOLOGICAL

graft-versus-tumor induction therapy

BIOLOGICAL

therapeutic allogeneic lymphocytes

DRUG

cyclophosphamide

DRUG

fludarabine phosphate

DRUG

mycophenolate mofetil

DRUG

tacrolimus

PROCEDURE

allogeneic bone marrow transplantation

PROCEDURE

peripheral blood stem cell transplantation

Trial Locations (1)

14642

James P. Wilmot Cancer Center at University of Rochester Medical Center, Rochester

All Listed Sponsors

lead

University of Rochester

OTHER

NCT00262886 - Donor Peripheral Stem Cell or Bone Marrow Transplant in Treating Patients With Relapsed or Refractory Metastatic Kidney Cancer | Biotech Hunter | Biotech Hunter